Direct-to-consumer marketing of predictive medical genetic tests: Assessment of current practices and policy recommendations

Journal of Public Policy and Marketing

Volumn 27, Issue 2, 2008, Pages 131-148

  Liu, Yuping ^a   Pearson, Yvette E ^b,c  

^a College of Business and Public Administration ^*

^b Institute for Ethics and Public Affairs

^c OLD DOMINION UNIVERSITY   (United States)

Author keywords

Direct to consumer marketing; Genetic testing; Health care; Internet marketing; Public policy

Indexed keywords

EID: 57749195311     PISSN: 07439156     EISSN: 15477207     Source Type: Journal    
DOI: 10.1509/jppm.27.2.131     Document Type: Review

References (76)

1. Alba, Joseph W. and J. Wesley Hutchinson (1987), "Dimensions of Consumer Expertise," Journal of Consumer Research, 13 (4), 411-54.
2. -, (2000), "Knowledge Calibration: What Consumers Know and What They Think They Know," Journal of Consumer Research, 27 (2), 123-56.
3. Alsever, Jennifer, Sidra Durst, Jeanette Borzo, and Saheli S.R. Datta (2006), "The Patient Knows Best," Business 2.0, 7 (9), (accessed May 31, 2008), [available at http://money.cnn.com/magazines/business2/ business2_archive/2006/10/01/8387104/ index.htm].
4. Andrews, Lori B., Jane E. Fullarton, Neil A. Holtzman, and Arno G. Muotulsky (1994), Assessing Genetic Risks: Implications for Health and Social Policy. Washington, DC: National Academy Press.
5. Auton, Frank (2004), "The Advertising of Pharmaceuticals Direct to Consumers: A Critical Review of the Literature and Debate," International Journal of Advertising, 23 (1), 5-52.
6. Bagozzi, Richard P., Mahesh Gopinath, and Prashanth U. Nyer (1999), "The Role of Emotion in Marketing," Journal of the Academy of Marketing Science, 27 (2), 184-206.
7. Bayley, Carol (2004), "The Challenge of Physician Education in Genetics," in Genetics and Ethics: An Interdisciplinary Study, Gerard Magill, ed. St. Louis: St. Louis University Press, 176-85.
8. Burke, Wylie (2004), "Genetic Testing in Primary Care," Annual Review of Genomics and Human Genetics, 5, 1-14.
9. -, David Atkins, Marta Gwinn, Alan Guttmacher, James Haddow, Joseph Lau, et al. (2002), "Genetic Test Evaluation: Information Needs of Clinicians, Policy Makers, and the Public," American Journal of Epistemology, 156 (4), 311-18.
10. Calfee, John E. (2002), "Public Policy Issues in Direct-to-Consumer Advertising of Prescription Drugs," Journal of Public Policy & Marketing, 21 (Fall), 174-93.
11. Cella, D., C. Hughes, A. Peterman, C. Chang, B.N. Peshkin, M.D. Schwartz, et al. (2002), "A Brief Assessment of Concerns Associated with Genetic Testing for Cancer: The Multidimensional Impact of Cancer Risk Assessment (Micra) Questionnaire," Health Psychology, 21 (6), 564-72.
12. Charnock, D., Sasha Shepperd, G. Needham, and R. Gann (1999), "Discern: An Instrument for Judging the Quality of Written Consumer Health Information on Treatment Choices," Journal of Epidemiology and Community Health, 53 (2), 105-11.
13. Choy, Angela, Zoe Hudson, Joy Pritts, and Janlori Goldman (2001), "Exposed Online: Why the New Federal Health Privacy Regulation Doesn't Offer Much Protection to Internet Users," report of the PEW Internet & American Life, (November), (accessed May 31, 2008), [available at http://www.pewinternet.org/pdfs/PIP_HPP_HealthPriv_report.pdf].
14. Clayton, Ellen Wright (2004), "Policy Challenges: Ethical, Legal, and Social Implications of Genetics," in Genetics and Ethics: An Interdisciplinary Study, Gerard Magill, ed. St. Louis: St. Louis University Press, 23-34.
15. Clinical Laboratories Improvement Amendments (1988), 42 CFR 493 § 176.
16. Cohen, Joshua P., Cherie Paquette, and Catherine P. Cairns (2005), "Switching Prescription Drugs to Over the Counter," British Medical Journal, 330 (7481), 39-40.
17. Conrad, Peter (2002), "Genetics and Behavior in the News: Dilemmas of a Rising Paradigm," in The Double-Edged Helix: Social Implications of Genetics in a Diverse Society, Joseph S. Alper, Catherine Ard, Adrienne Asch, and Jon Beckwith, eds. Baltimore: Johns Hopkins University Press, 151-74.
18. De Melo-Martin, Immaculada (2006a), "Furthering Injustice Against Women: Genetic Information, Moral Obligations, and Gender," Bioethics, 20 (6), 301-307.
19. -, (2006b), "Genetic Testing: The Appropriate Means to the Desired Goal," Journal of Bioethical Inquiry, 3 (3), 167-77.
20. Donohue, Julie M., Marisa Cevasco, and Meredith B. Rosenthal (2007), "A Decade of Direct-to-Consumer Advertising of Prescription Drugs," New England Journal of Medicine, 357 (7), 673-81.
21. Edell, Julie A. and Marian Chapman Burke (1987), "The Power of Feelings in Understanding Advertising Effects," Journal of Consumer Research, 14 (3), 421-33.
22. Entwhistle, Vikki A., T.A. Sheldon, A.J. Sowden, and I.S. Watt (1996), "Supporting Consumer Involvement in Decision-Making: What Constitutes Quality in Consumer Health Information," International Journal of Quality in Health Care, 8 (5), 425-37.
23. FDA Amendments Act (2007), Public Law No. 110-85 § 1103, 121 Stat. 824.
24. Fox, Susannah (2006), "Online Health Search 2006," PEW Internet & American Life, (October 29), (accessed July 23, 2007), [available at http://www.pewinternet.org/pdfs/PIP_Online_ Health_2006.pdf.
25. FTC (2000), "Dot Com Disclosures: Information About Online Advertising," (accessed July 23, 2007), [available at http://www.ftc.gov/ bcp/conline/pubs/buspubs/dotcom/].
26. -, (1984a), "FTC Policy Statement on Deception," 103 F.T.C. 110, 174.
27. -, (1984b), "FTC Policy Statement Regarding Advertising Substantiation," 104 F.T.C. 648, 839.
28. Genetic Information Nondiscrimination Act (2008), Public Law 110-233.
29. Goddard, Katrina, Cynthia Moore, Denae Ottman, Kathleen Szegda, Linda Bradley, and Muin Khoury (2007), "Awareness and Use of Direct-to-Consumer Nutrigenomic Tests," Genetics IN Medicine, 9 (8), 510-17.
30. Gollust, Sarah E., Sara Chandros Hull, and Benjamin S. Wilfond (2002), "Limitations of Direct-to-Consumer Advertising for Clinical Genetic Testing," Journal of the American Medical Association, 288 (14), 1762-67.
31. -, Benjamin S. Wilfond, and Sara Chandros Hull (2003), "Direct-to-Consumer Sales of Genetic Services on the Internet," Genetics in Medicine, 5 (4), 332-37.
32. GPPC (2007a), "Amendment to Pending Bill Would Require IOM Study of Genetic Tests," GPPC eNews, 19, (accessed June 13, 2007), [available at http://www.dnapolicy.org/news.enews. php?action=detail2&newsletter_id= 22].
33. -, (2007b), "Myriad Genetics Launches Brca Testing Ad Campaign in Northeast," (accessed July 19, 2008), [available at http://www.dnapolicy. org/news.release.php?action=detail& pressrelease_id=85].
34. -, (2007c), "Survey of Direct-to-Consumer Testing Statutes and Regulations," (accessed August 6, 2007), [available at http://www. dnapolicy.org/resources/DTCStateLawChart.pdf].
35. Harris Interactive Inc. (2007), "The Harris Poll #76," (July 31), (accessed August 4, 2007), [available at http://www.harrisinteractive.com/ harris_poll/index.asp?PID=792].
36. Health Insurance Portability and Accountability Act (1996), 45 CFR § 164.102-164.534.
37. Heather, Justin Lee (2001), "Liability for Direct-to-Consumer Advertising and Drug Information on the Internet," Defense Counsel Journal, 68 (4), 412-20.
38. Herel, Suzanne (2002), "Research Questions Breast Cancer Risk: Report Suggests Mutant Gene May Not Warrant Mastectomy," San Francisco Chronicle, (August 21), A1.
39. Hofrnan, Karen, Ellen S. Tambor, Gary A. Chase, Gail Geller, Ruth R. Faden, and Neil A. Holtzman (1993), "Physicians' Knowledge of Genetics and Genetic Tests," Academic Medicine, 68 (8), 625-32.
40. Hudson, Kathy, Gail H. Javitt, Wylie Burke, and Peter Byers (2007), "ASHG Statement on Direct-to-Consumer Genetic Testing in the United States," American Journal of Human Genetics, 81 (3), 635-37.
41. Jacobs, Lori R. (1998), "Prescription to Over-the-Counter Drug Reclassification," American Family Physician, 57 (9), 2209-2214.
42. Javitt, Gail H. (2007), "In Search of a Coherent Framework: Options for FDA Oversight of Genetic Tests," Food and Drug Law Journal, 62 (4), 617-52.
43. -, and Kathy Hudson (2006a), "Federal Neglect: Regulation of Genetic Testing," Issues in Science and Technology, 22 (3), 59-66.
44. -, (2006b), "Public Health at Risk: Failures in Oversight of Genetic Testing Laboratories," Genetics and Public Policy Center, (accessed May 31, 2007), [available at http://www.dnapolicy.org/images/reportpdfs/ PublicHealthAtRiskFinalWithCover.pdf].
45. Katsanis, S.H., Gail H. Javitt, and Kathy Hudson (2008), "A Case Study of Personalized Medicine," Science, 320 (5872), 53-54.
46. Kelly, Pat (2004), "DTC Advertising's Benefits Outweigh Its Imperfections," Health Affairs, W4 (April 28), 246-48.
47. kSERO Corporation (2003), "New Poll Shows Dramatic Rise in Americans' 'DNA I.Q.': Threefold Increase Delights Educators, but Is It Enough?" (accessed June 3, 2007), [available at http://www.eurekalert.org/ pub_releases/2003-02/kc-nps022603.php].
48. LaTour, Michael S., Robin L. Snipes, and Sara J. Bliss (1996), "Don't Be Afraid to Use Fear Appeals: An Experimental Study," Journal of Advertising Research, 36 (2), 59-67.
49. Lee, Thomas H. and Troyen A. Brennan (2002), "Direct-to-Consumer Marketing of High-Technology Screening Tests," New England Journal of Medicine, 346 (7), 529-31.
50. Lerman, Caryn and Alexandra E. Shields (2004), "Genetic Testing for Cancer Susceptibility: The Promise and the Pitfalls," Nature Reviews Cancer, 4 (3), 235-41.
51. Lexchin, Joel and Barbara Mintzes (2002), "Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No," Journal of Public Policy & Marketing, 21 (Fall), 194-201.
52. Liu, Yifei, William R. Doucette, Karen B. Farris, and Dhananjay Nayakankuppam (2005), "Drug Information-Seeking Intention and Behavior After Exposure to Direct-to-Consumer Advertisement of Prescription Drugs," Research in Social and Administrative Pharmacy, 1 (2), 251-69.
53. Macias, Wendy and Liza Stavchansky Lewis (2005), "How Well Do Direct-to-Consumer, DTC, Prescription Drug Web Sites Meet FDA Guidelines and Public Policy Concerns?" Health Marketing Quarterly, 22 (4), 45-71.
54. Main, Kelley J., Jennifer J. Argo, and Bruce A. Huhmann (2004), "Pharmaceutical Advertising in the USA: Information or Influence?" International Journal of Advertising, 23 (1), 119-42.
55. McCabe, Linda L. and Edward R.B. McCabe (2004), "Direct-to-Consumer Genetic Testing: Access and Marketing," Genetics IN Medicine, 6 (1), 58-59.
56. Munson, Ronald (2007), "Genetize Me! The Case for Direct-to-Consumer Genetic Testing," in Ethics of Genetic Commerce, Robert Kolb, ed. Boston: Blackwell Publishing, 55-69.
57. Myriad Genetics (2007), "Myriad 2007 Annual Report," (accessed May 28, 2008), [available at http://www.myriad.com/ downloads/Myriad-Annual- Report-2007.pdf].
58. National Institutes of Health Task Force on Genetic Testing (1997), "Final Report of the Task Force on Genetic Testing," (accessed August 4, 2007), [available at http://www.genome.gov/10001733].
59. Neuendorf, Kimberly A. (2002), The Content Analysis Guidebook. Thousand Oaks, CA: Sage Publications.
60. Pines, Wayne L. (1999), "A History and Perspective on Direct-to-Consumer Promotion," Food and Drug Law Journal, 54 (4), 489-518.
61. Racine, Eric, HZ Adriaan van Der Loos, and Judy Illes (2007), "Internet Marketing of Neuroproducts: New Practices and Healthcare Policy Challenges," Cambridge Quarterly of Healthcare Ethics, 16 (2), 181-94.
62. Ringold, Debra Jones (2005), "Vulnerability in the Marketplace: Concepts, Caveats, and Possible Solutions," Journal of Macro-marketing, 25 (2), 202-214.
63. Roseman, Ira J. (1991), "Appraisal Determinants of Discrete Emotions," Cognition and Emotion, 5 (3), 161-200.
64. Securities and Exchange Commission (2000), "SEC Interpretation: Use of Electronic Media," 17 CFR Parts 231, 241, and 271.
65. Sewak, Saurabh S., Noel E. Wilkin, John P. Bentley, and Mickey C. Smith (2005), "Direct-to-Consumer Advertising via the Internet: The Role of Web Site Design," Research in Social and Administrative Pharmacy, 1 (2), 289-309.
66. Shepperd, Sasha, Peter Farndon, Vivian Grainge, Sandy Oliver. Michael Parker, Rafael Perera, et al. (2006), "Discern-Genetics: Quality Criteria for Information on Genetic Testing," European Journal of Human Genetics, 14(7), 1179-88.
67. Silberg, William, George D. Lundberg, and Robert A. Musacchio (1997), "Assessing, Controlling, and Assuring the Quality of Medical Information on the Internet," Journal of the American Medical Association, 277 (15), 1244-45.
68. Tapscott, Don and Anthony D. Williams (2006), Wikinomics: How Mass Collaboration Changes Everything. New York: Portfolio.
69. Taylor, Humphrey (2002), "The Harris Poll #26," Harris Interactive, (June 5), (accessed August 1, 2007), [available at http://www.harrisinteractive.com/harris_poll/index.asp?PID=304].
70. Taylor, Matthew R.G., Janice G. Edwards, and Lisa Ku (2006), "Lost in Transition: Challenges in the Expanding Field of Adult Genetics," American Journal of Medical Genetics: Part C: Seminars in Medical Genetics, 142C (4), 294-303.
71. Waack, Katherine E., Michael E. Ernst, and Mark A. Graber (2004), "Informational Content of Official Pharmaceutical Industry Web Sites About Treatments for Erectile Dysfunction," Annals of Pharmacotherapy, 38 (12), 2029-2034.
72. Weissman, Joel S., David Blumenthal, Alvin J. Silk, Michael Newman, Kinga Zapert, Robert Leitman, et al. (2004), "Physicians Report on Patient Encounters Involving Direct-to-Consumer Advertising," Health Affairs, W4 (April 24), 219-33.
73. Wilkes, Michael S., Robert A. Bell, and Richard L. Kravitz (2000), "Direct-to-Consumer Prescription Drug Advertising: Trends, Impact, and Implications," Health Affairs, 19 (2), 110-28.
74. Williams-Jones, Bryn (2003), "Where There's a Web, There's a Way: Commercial Genetic Testing and the Internet," Community Genetics, 6(1), 46-57.
75. Wolfe, Sidney M. (2002), "Direct-to-Consumer Advertising: Education or Emotion Promotion?" New England Journal of Medicine, 346 (7), 524-26.
76. Woloshin, Steven, Lisa M. Schwartz, Jennifer Tremmel, and H. Gilbert Welch (2001), "Direct-to-Consumer Advertisements for Prescription Drugs: What Are Americans Being Sold?" The Lancet, 358 (October), 1141-46.